Skip to main content
NCBI home page
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2022 Jan 25;9:762248. doi: 10.3389/fchem.2021.762248

Three-Component Synthesis of Some New Coumarin Derivatives as Anticancer Agents

Latifah A Alshabanah 1, Laila A Al-Mutabagani 1, Sobhi M Gomha 2,3,*,†, Hoda A Ahmed 2,4
PMCID: PMC8822056  PMID: 35145952

Abstract

A three-component reaction for the synthesis of novel 3-heteroaryl-coumarin utilizing acetylcoumarin synthon under ultrasonic irradiation was developed using chitosan-grafted poly(vinylpyridine) as an eco-friendly catalyst. The process is a simple, facile, efficient procedure for the preparation of compounds displaying a thiazole ring linked to coumarin moiety. Moreover, all the products were evaluated for their anticancer activities against HEPG2-1. The results revealed that three new compounds showed promising anticancer activities.

Keywords: acetylcoumarin, hydrazonoyl halides, multicomponent synthesis, ultrasonic radiation, anticancer

Introduction

Today, the second cause of death in the world is cancer (Gomes et al., 2011). Chemotherapy has become one of the important methods for cancer treatment. The identification of novel, more potent, selective, and less toxic antitumor agents is the main aim for the researchers due to its widespread, rapid development and the severe infection of the tumor diseases. In the efforts to offer suitable anticancer drugs, medicinal researchers have focused on coumarin systems.

Coumarin is a naturally occurring material as well as a versatile synthetic scaffold exhibiting a wide spectrum of biological impacts including potential anticancer activities (Vosooghi et al., 2010) such as seselin (skin cancer) (Nishino et al., 1990), acronycin (lung, colon, and ovarian cancers) (Thakur et al., 2015), calanone (leukemia and cervical carcinoma) (Emami and Dadashpour, 2015), and tephrosin (lung cancer) (Lin et al., 2014). In addition, coumarin derivatives have a tremendous ability to regulate a diverse range of cellular pathways that can be explored for their selective anticancer activities (Geisler et al., 2011; Saidu et al., 2012). Moreover, the biological evaluations of coumarins revealed that the engrossment of innumerable pathways via coumarins acts as anticancer agents. They target a number of pathways in cancer like as kinase inhibition, cell cycle arrest, heat shock protein (HSP90) inhibition, angiogenesis inhibition, monocarboxylate transporters inhibition, antimitotic activity, carbonic anhydrase inhibition, telomerase inhibition, aromatase inhibition, and sulfatase inhibition (Ekowati et al., 2010; Li et al., 2010; Wang et al., 2011; Bhattarai et al., 2021).

Many investigations indicated that 1,3-thiazole derivatives possessed potential anticancer activities against various cancer types (Figure 1) (Luzina and Popov, 2009; Kashyap et al., 2018; Popsavin et al., 2007; Mavrova et al., 2009). Moreover, researchers found that the 1,3,4-thiadiazole derivatives exhibited anticancer activities with excellent IG50 and IC50 (Figure 1) (Liaras et al., 2018; Matysiak and Opolski, 2006; Kumar et al., 2010; Bhole and Bhusari, 2010). Many reports also revealed that the link between thiazole or thiadiazole groups and the coumarin moiety has broad spectra of pharmacological activities especially antitumor activities (Figure 2) (Gomha et al., 2015a; Gomha et al., 2015b; Gomha and Abdel-Aziz, 2015).

FIGURE 1.

FIGURE 1

Open in a new tab

Lead compounds among thiazoles and thiadiazoles with anticancer activities.

FIGURE 2.

FIGURE 2

Open in a new tab

Coumarin-based thiazoles or thiadiazoles with anticancer activities and the targeted compounds.

Multicomponent reactions (MCR) are one-pot mechanisms that produce a single product with at least three components, combining most or all of the starting materials (Marcaccini et al., 2003; Shaabani et al., 2008; Bachman et al., 2012; Gomha and Riyadh, 2014; Mamaghani and Hossein Nia, 2021), attributed to their reaction simplicity and high efficiency compared with multistage procedures. Furthermore, the ultrasound irradiation technique has been accomplished as an efficient heating source for organic reactions in synthetic organic chemistry. The main advantages of ultrasound-assisted reactions are shorter reaction time, simple experimental procedure, high yields, more selectivity, and clean processes (Xu et al., 2007; Jarag et al., 2011; Singh et al., 2013). One of the beneficial effects of ultrasound irradiation is playing a vital role in chemistry, especially in cases where classical tools require drastic conditions or long reactions times (Cravotto and Cintas, 2006; Cravotto et al., 2010; Pizzuti et al., 2010).

Chitosan is generated by alkaline hydrolysis of chitin (Gupta and Ravi Kumar, 2000). It is the naturally occurring copolymer polysaccharide including both glucosamine and acetylglucosamine units. Chitosan is used, in heterocyclic synthesis, as a heterogeneous phase transfer basic biocatalyst (Guibal, 2005; Qin et al., 2012; Watile and Bhanage, 2012; Alshabanah et al., 2021). Chitosan’s key drawback is that it is extremely hygroscopic and can form gels, making it difficult to recycle from the reaction mixture. To overcome this limitation, chitosan-grafted poly(vinylpyridine) has been used as a basic biocatalyst with high catalytic activities (Fu et al., 2011), which can be easily recycled and has a better basic character owing to the presence of pyridine rings.

In the light of the above findings and in continuation of our efforts to synthesize new antitumor compounds (Abbas et al., 2015; Gomha et al., 2015c; Dawood and Gomha, 2015; Gomha et al., 2016a; Gomha et al., 2016b; Gomha et al., 2017a; Gomha et al., 2017b; Tao et al., 2018; Gomha et al., 2021), the aim of the present work is to design and synthesize thiazoles and thiadiazoles linked to position 3 of coumarin as novel 3-azolylcoumarins as expected anticancer agents, utilizing sonication technique and using chitosan-grafted poly(vinylpyridine) as an eco-friendly catalyst.

Methods and Methodology

The mass spectra were recorded on GCMS-Q1000-EX Shimadzu and GCMS 5988-A HP spectrometers, and the ionizing voltage was 70 eV (Tokyo, Japan). The IR spectra were recorded in potassium bromide discs on Shimadzu FT IR 8101 PC infrared spectrophotometer (Shimadzu, Tokyo, Japan). The 1H- and 13C-NMR spectra were recorded on Varian Mercury VXR-300 spectrometer (300 MHz for 1H-NMR and 75 MHz for 13C-NMR), and the chemical shifts were related to those of the solvent DMSO-d 6 (Varian, Inc., Karlsruhe, Germany). All reactions were followed by thin-layer chromatography (TLC) (silica gel, Aluminum Sheets 60 F254, Merck, Cairo, Egypt). Elemental analyses were carried out at the Microanalytical Centre of Cairo University, Giza, Egypt. Sonication was performed in Shanghai Branson-CQX ultrasonic cleaner at a frequency of 40 kHz, and ultrasonic power was kept at 250 W.

General Procedure for Synthesis of 1,3-Thiazole Derivatives 6a–i

Method A: Triethylamine (TEA) (0.07 ml) was added to a mixture of the appropriate hydrazonoyl halides 5a–i (1 mmol), thiosemicarbazide 4 (0.091 g, 1 mmol), and 3-acetyl-6-methyl-2H-chromen-2-one (3) (0.202 g, 1 mmol) in 20 ml of dioxane. The formed solution was irradiated by an ultrasonic generator in a water bath at 50°C for 20–60 min. Irradiation was continued till all of the starting materials have disappeared and the product was formed, monitored by TLC. The red precipitate that formed after cooling was filtered off, washed with EtOH, dried, and recrystallized from dimethylformamide (DMF) to give the corresponding thiazoles 6a–i. The physical constants of products 6a–i are listed below.

Method B: A mixture of equimolar amounts of 3, 4 and the appropriate 5a–i (1 mmol each) in dioxane (10 ml) containing chitosan (10 mol%) was irradiated by an ultrasonic generator in a water bath at 50°C for 20–60 min (monitored by TLC). The hot solution was filtered to remove chitosan, and excess solvent was removed under reduced pressure. The reaction mixture was triturated with methanol, and the product separated was filtered, washed with methanol, dried, and recrystallized from DMF to give compounds 6a–i.

Method C: The same procedure in method B using grafted chitosan (10 mol%) instead of chitosan.

6-Methyl-3-(1-(2-(4-methyl-5-(phenyldiazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6a)

Red solid, m.p. 183°C–185°C; IR (KBr) ν cm−1: 3,427 (NH), 1,724 (C═O), 1,602 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2.67 (s, 3H, CH3), 6.63–7.83 (m, 8H, Ar–H), 8.29 (s, 1H, coumarin-H4), 11.16 (s, br, 1H, NH) ppm; 13C-NMR (DMSO-d 6): δ 11.3, 16.2, 20.1 (CH3), 115.6, 118.5, 125.4, 127.5, 127.8, 128.2, 128.7, 132.9, 133.1, 133.5, 133.9, 140.5, 140.8, 146.0, 151.4 (Ar–C), 168.1 (C═O) ppm; MS m/z (%): 417.13 (M+, 63), 351 (42), 299 (69), 247 (41), 93 (22), 80 (100), 64 (70). Anal. calcd for C22H19N5O2S (417.49): C, 63.29; H, 4.59; N, 16.78. Found: C, 63.21; H, 4.50; N, 16.69%.

6-Methyl-3-(1-(2-(4-methyl-5-(p-tolyldiazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6b)

Red solid, m.p. 170°C–172°C; IR (KBr) ν cm−1: 3,428 (NH), 1,729 (C═O), 1,600 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2.73 (s, 3H, CH3), 6.65–7.71 (m, 7H, Ar–H), 8.29 (s, 1H, coumarin-H4), 11.18 (s, br, 1H, NH) ppm; MS m/z (%): 431 (M+, 100), 365 (40), 313 (26), 214 (27), 106 (53), 90 (100), 65 (70). Anal. calcd for C23H21N5O2S (431.51): C, 64.02; H, 4.91; N, 16.23. Found: C, 64.00; H, 4.83; N, 16.14%.

6-Methyl-3-(1-(2-(4-methyl-5-(m-tolyldiazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6c)

Red solid, m.p. 183°C–185°C; IR (KBr) ν cm−1: 3,426 (NH), 1,723 (C═O), 1,609 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.26 (s, 3H, CH3), 2.39 (s, 3H, CH3), 2.75 (s, 3H, CH3), 6.65–7.66 (m, 7H, Ar–H), 8.29 (s, 1H, coumarin-H4), 10.86 (s, br, 1H, NH) ppm; MS m/z (%): 431 (83), 384 (41), 214 (23), 106 (87), 90 (100), 65 (76). Anal. calcd for C23H21N5O2S (431.51): C, 64.02; H, 4.91; N, 16.23. Found: C, 64.01; H, 4.84; N, 16.06%.

3-(1-(2-(5-((4-Methoxyphenyl)diazenyl)-4-methylthiazol-2-yl)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (6d)

Red solid, m.p. 162°C–164°C; IR (KBr) ν cm−1: 3,416 (NH), 1,724 (C═O), 1,604 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.70 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.64–7.77 (m, 7H, Ar–H), 8.29 (s, 1H, coumarin-H4), 11.15 (s, br, 1H, NH) ppm; MS m/z (%): 447 (M+, 42), 431 (47), 342 (36), 241 (19), 108 (46), 80 (100), 64 (92). Anal. calcd for C23H21N5O3S (447.51): C, 61.73; H, 4.73; N, 15.65. Found: C, 61.63; H, 4.59; N, 15.60%.

3-(1-(2-(5-((4-Chlorophenyl)diazenyl)-4-methylthiazol-2-yl)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (6e)

Red solid, m.p. 197°C–199°C; IR (KBr) ν cm−1: 3,419 (NH), 1,726 (C═O), 1,608 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.39 (s, 3H, CH3), 2.74 (s, 3H, CH3), 6.65–7.88 (m, 7H, Ar–H), 8.29 (s, 1H, coumarin-H4), 11.08 (s, br, 1H, NH) ppm; MS m/z (%): 451 (M+, 73), 395 (40), 214 (18), 127 (97), 80 (91), 64 (100). Anal. calcd for C22H18ClN5O2S (451.93): C, 58.47; H, 4.01; N, 15.50. Found: C, 58.36; H, 3.84; N, 15.42%.

3-(1-(2-(5-((4-Bromophenyl)diazenyl)-4-methylthiazol-2-yl)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (6f)

Orange solid, m.p. 170°C–173°C; IR (KBr) ν cm−1: 3,422 (NH), 1,723 (C═O), 1,601 (C═N); 1H-NMR (DMSO-d 6) δ: 2.12 (s, 3H, CH3), 2.39 (s, 3H, CH3), 2.74 (s, 3H, CH3), 6.67–7.79 (m, 7H, Ar–H), 8.29 (s, 1H, coumarin-H4), 10.68 (s, br, 1H, NH) ppm; MS m/z (%): 496 (M+, 49), 377 (53), 214 (27), 171 (48), 92 (86), 65 (100). Anal. calcd for C22H18BrN5O2S (496.38): C, 53.23; H, 3.66; N, 14.11. Found: C, 53.04; H, 3.49; N, 14.02%.

6-Methyl-3-(1-(2-(4-methyl-5-((4-nitrophenyl)diazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6g)

Brown solid, m.p. 213°C–215°C; IR (KBr) ν cm−1: 3,425 (NH), 1,729 (C═O), 1,603 (C═N); 1H-NMR (DMSO-d 6) δ: 2.25 (s, 3H, CH3), 2.45 (s, 3H, CH3), 2.63 (s, 3H, CH3), 6.65–8.21 (m, 7H, Ar–H), 8.30 (s, 1H, coumarin-H4), 11.09 (s, br, 1H, NH) ppm; MS m/z (%): 462 (M+, 32), 375 (27), 214 (100), 138 (37), 108 (39), 65 (73). Anal. calcd for C22H18N6O4S (462.48): C, 57.14; H, 3.92; N, 18.17. Found: C, 57.04; H, 3.83; N, 18.03%.

3-(1-(2-(5-((2,4-Dichlorophenyl)diazenyl)-4-methylthiazol-2-yl)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (6h)

Red solid, m.p. 191°C–193°C; IR (KBr) ν cm−1: 3,426 (NH), 1,725 (C═O), 1,604 (C═N); 1H-NMR (DMSO-d 6) δ: 2.13 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.73 (s, 3H, CH3), 6.64–7.79 (m, 6H, Ar–H), 8.29 (s, 1H, coumarin-H4), 10.73 (s, br, 1H, NH) ppm; MS m/z (%): 486 (M+, 73), 451 (60), 357 (48), 214 (29), 161 (85), 80 (71), 64 (100). Anal. calcd for C22H17Cl2N5O2S (486.37): C, 54.33; H, 3.52; N, 14.40. Found: C, 54.27; H, 3.50; N, 14.27%.

6-Methyl-3-(1-(2-(5-(phenyldiazenyl)-4-(thiophen-2-yl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6i)

Orange solid, m.p. 166°C–168°C; IR (KBr) ν cm−1: 3,420 (NH), 1,727 (C═O), 1,605 (C═N); 1H-NMR (DMSO-d 6) δ: 2.18 (s, 3H, CH3), 2.39 (s, 3H, CH3), 6.68–8.06 (m, 11H, Ar–H), 8.39 (s, 1H, coumarin-H4), 11.50 (s, br, 1H, NH) ppm; MS m/z (%): 485 (M+, 27), 456 (83), 383 (69), 214 (18), 135 (14), 111 (100), 77 (79). Anal. calcd for C25H19N5O2S2 (485.58): C, 61.84; H, 3.94; N, 14.42. Found: C, 61.71; H, 3.88; N, 14.36%.

Alternate Synthesis of 6a

  • i) Synthesis of 2-(1-(6-methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazine-1-carbothioamide (7). A catalytic amount of concentrated hydrochloric acid was added to a mixture of 3-acetyl-6-methyl-2H-chromen-2-one (3) (2.02 g, 10 mmol) and thiosemicarbazide 4 (0.91 g, 10 mmol) in 50 ml of ethanol. The reaction mixture was irradiated by an ultrasonic generator in a water bath at 50°C for 30 min. The precipitate that formed after cooling was filtered, washed with ethanol, and recrystallized from acetic acid to give a pure product of compound 7 as yellowish-white solid in 72% yield; m.p. 231°C–233°C; IR (KBr) ν cm−1: 3,431, 4,237, 3,159 (NH and NH2), 1,726 (C═O), 1,604 (C═N); 1H-NMR (DMSO-d 6) δ: 2.25 (s, 3H, CH3), 2.37 (s, 3H, CH3), 7.30–7.53 (m, 3H, Ar–H), 7.92 (s, 1H, coumarin-H4), 8.37 (s, br, 2H, NH2), 10.40 (s, br, 1H, NH) ppm; MS m/z (%): 275 (M+, 63), 214 (49), 175 (29), 111 (100), 77 (69), 63 (82). Anal. calcd for C13H13N3O2S (275.33): C, 56.71; H, 4.76; N, 15.26. Found: C, 56.58; H, 4.71; N, 15.09%.

Reaction of thiosemicarbazone 7 with 2-oxo-N-phenylpropanehydrazonoyl chloride (5a)

Chitosan-grafted poly(vinylpyridine) (0.1 g) was added to a stirred mixture of thiosemicarbazone 7 (0.275 g, 1 mmol) and 2-oxo-N-phenylpropanehydrazonoyl chloride (5a) (0.196 g, 1 mmol) in dioxane (15 ml). The reaction mixture was irradiated by an ultrasonic generator in a water bath at 40°C for 30 min. The hot solution was filtered to remove g-chitosan and excess solvent was removed under reduced pressure. The reaction mixture was triturated with methanol, and the product separated was filtered, washed with methanol, dried, and recrystallized from DMF to give the corresponding product 6a, which was identical in all aspects (m.p., mixed m.p., and IR spectra) with those obtained from the one-pot synthesis of 3 + 4 + 5a.

General Procedure for Synthesis of 1,3,4-Thiadiazole Derivatives 11a–f

Method A: A mixture of 3-acetyl-6-methyl-2H-chromen-2-one (3) (2.02 g, 10 mmol), methyl hydrazinecarbodithioate (10) (0.122 g, 1 mmol), and the appropriate hydrazonoyl halides 5a–f (1 mmol) in ethanol (20 ml) containing TEA (0.07 ml) was stirred at room temperature for 4–8 h. The resulting solid was collected and recrystallized from DMF to give the corresponding 1,3,4-thiadiazoles 11a–f. Products 11a–f together with their physical constants are listed below.

Method B: A mixture of equimolar amounts of 3, 10, and the appropriate 5a–f (1 mmol each) in ethanol (20 ml) containing chitosan (0.1 g) was irradiated by an ultrasonic generator in a water bath at 25°C for 10–30 min (monitored by TLC). The hot solution was filtered to remove chitosan, and excess solvent was removed under reduced pressure. The reaction mixture was triturated with methanol, and the product separated was filtered, washed with methanol, dried, and recrystallized from DMF to give compounds 11a–f.

Method C: The same procedure in method B using grafted chitosan (0.1 g) instead of chitosan.

3-(1-((5-Acetyl-3-phenyl-1,3,4-thiadiazol-2(3H)-ylidene)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (11a)

Yellow solid, m.p. 214°C–216°C; IR (KBr) ν cm−1: 1,726, 1,696 (2C═O), 1,602 (C═N); 1H-NMR (DMSO-d 6) δ: 2.37 (s, 3H, CH3), 2.44 (s, 3H, CH3), 2.57 (s, 3H, CH3), 7.34–7.72 (m, 8H, Ar–H), 8.56 (s, 1H, coumarin-H4) ppm; 13C-NMR (DMSO-d 6): δ 14.7, 20.1, 29.9 (CH3), 107.6, 115.8, 120.4, 125.5, 127.3, 127.7, 128.7, 129.5, 130.1, 134.1, 135.3, 140.0, 146.8, 152.7 (Ar–C), 168.5, 195.0 (C═O) ppm; MS m/z (%): 418 (M+, 42), 338 (53), 214 (4), 177 (51), 90 (62), 64 (100). Anal. calcd for C22H18N4O3S (418.47): C, 63.14; H, 4.34; N, 13.39. Found: C, 63.05; H, 4.31; N, 13.26%.

3-(1-((5-Acetyl-3-(p-tolyl)-1,3,4-thiadiazol-2(3H)-ylidene)hydrazono)ethyl)-6-methyl-2H-chromen-2-one (11b)

Yellow solid, m.p. 201°C–203°C; IR (KBr) ν cm−1: 1,724, 1,699 (2C═O), 1,606 (C═N); 1H-NMR (DMSO-d 6) δ: 2.25 (s, 3H, CH3), 2.37 (s, 3H, CH3), 2.41 (s, 3H, CH3), 2.58 (s, 3H, CH3), 7.31–7.63 (m, 6H, Ar–H), 7.73 (s, 1H, Ar–H), 8.57 (s, 1H, coumarin-H4) ppm; MS m/z (%): 432 (M+, 68), 331 (60), 186 (44), 158 (41), 91 (100), 77 (70). Anal. calcd for C23H20N4O3S (432.50): C, 63.87; H, 4.66; N, 12.95. Found: C, 63.71; H, 4.62; N, 12.84%.

Ethyl 5-((1-(6-methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)-4-phenyl-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate (11c)

Yellow solid, m.p. 190°C–192°C; IR (KBr) ν cm−1: 1,740, 1,722 (2C═O), 1,603 (C═N); 1H-NMR (DMSO-d 6) δ: 1.30 (t, 3H, J = 6.9 Hz, CH2CH3), 2.37 (s, 3H, CH3), 2.62 (s, 3H, CH3), 4.27 (q, 2H, J = 6.9 Hz, CH2CH3), 7.22–7.69 (m, 7H, Ar–H), 7.73 (s, 1H, Ar–H), 8.55 (s, 1H, coumarin-H4) ppm; MS m/z (%): 448 (M+, 26), 338 (39), 214 (63), 158 (50), 90 (86), 77 (100). Anal. calcd for C23H20N4O4S (448.50): C, 61.60; H, 4.50; N, 12.49. Found: C, 61.52; H, 4.38; N, 12.36%.

Ethyl 5-((1-(6-methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)-4-(p-tolyl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate (11d)

Yellow solid, m.p. 171°C–173°C; IR (KBr) ν cm−1: 1,742, 1,722 (2C═O), 1,606 (C═N); 1H-NMR (DMSO-d 6) δ: 1.27 (t, 3H, J = 6.9 Hz, CH2CH3), 2.23 (s, 3H, CH3), 2.37 (s, 3H, CH3), 2.65 (s, 3H, CH3), 4.29 (q, 2H, J = 6.9 Hz, CH2CH3), 7.33–7.56 (m, 6H, Ar–H), 7.71 (s, 1H, Ar–H), 8.55 (s, 1H, coumarin-H4) ppm; MS m/z (%): 462 (M+, 70), 384 (94), 331 (40), 186 (36), 91 (100), 77 (69). Anal. calcd for C24H22N4O4S (462.52): C, 62.32; H, 4.79; N, 12.11. Found: C, 62.19; H, 4.64; N, 12.03%.

5-((1-(6-Methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)-N,4-diphenyl-4,5-dihydro-1,3,4-thiadiazole-2-carboxamide (11e)

Yellow solid, m.p. 190°C–192°C; IR (KBr) ν cm−1: 3,427 (NH), 1,740, 1,679 (2C═O), 1,600 (C═N); 1H-NMR (DMSO-d 6) δ: 2.37 (s, 3H, CH3), 2.57 (s, 3H, CH3), 7.34–7.57 (m, 12H, Ar–H), 7.72 (s, 1H, Ar–H), 8.56 (s, 1H, coumarin-H4), 10.63 (s, br, 1H, NH) ppm; MS m/z (%): 495 (M+, 49), 418 (37), 331 (41), 186 (54), 91 (100), 77 (86), 64 (61). Anal. calcd for C27H21N5O3S (495.56): C, 65.44; H, 4.27; N, 14.13. Found: C, 65.28; H, 4.21; N, 14.05%.

6-Methyl-3-(1-((3-phenyl-5-(thiophene-2-carbonyl)-1,3,4-thiadiazol-2(3H)-ylidene)hydrazono)ethyl)-2H-chromen-2-one (11f)

Yellow solid, m.p. 240°C–242°C; IR (KBr) ν cm−1: 1,726, 1,693 (2C═O), 1,607 (C═N); 1H-NMR (DMSO-d 6) δ: 2.37 (s, 3H, CH3), 2.64 (s, 3H, CH3), 7.34–7.69 (m, 10H, Ar–H), 7.71 (s, 1H, Ar–H), 8.55 (s, 1H, coumarin-H4) ppm; MS m/z (%): 486 (M+, 27), 426 (60), 330 (39), 111 (51), 80 (100), 64 (89). Anal. calcd for C25H18N4O3S2 (486.56): C, 61.71; H, 3.73; N, 11.52. Found: C, 61.58; H, 3.64; N, 11.41%.

Alternate Synthesis of 11a

  • i) Synthesis of methyl 2-(1-(6-methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazine-1-carbodithioate (12). To a solution of 3-acetyl-6-methyl-2H-chromen-2-one (3) (2.02 g, 10 mmol) in 2-propanol (20 ml), methyl hydrazinecarbodithioate (10) (1.22 g, 10 mmol) was added. The reaction mixture was irradiated by an ultrasonic generator in a water bath at 30°C for 30 min. The precipitate that formed after cooling was filtered, washed with ethanol, and recrystallized from acetic acid to give pure product of compound 12 as yellowish-white solid in 68% yield; m.p. 175°C–177°C; IR (KBr) ν cm−1: 3,420 (NH), 1,723 (C═O), 1,604 (C═N); 1H-NMR (DMSO-d 6) δ: 2.25 (s, 3H, CH3), 2.37 (s, 3H, CH3), 2.57 (s, 3H, SCH3), 7.33 (d, J = 9 Hz, 1H, Ar–H), 7.54 (d, J = 9 Hz, 1H, Ar–H), 7.71 (s, 1H, Ar–H), 8.55 (s, 1H, coumarin-H4), 11.79 (s, br, 1H, NH) ppm; MS m/z (%): 306 (M+, 18), 186 (40), 158 (37), 128 (39), 90 (100), 77 (86), 64 (75). Anal. calcd for C14H14N2O2S2 (306.40): C, 54.88; H, 4.61; N, 9.14. Found: C, 54.70; H, 4.58; N, 9.06%.

  • ii) Reaction of carbodithioate 12 with 2-oxo-N-phenylpropanehydrazonoyl chloride (5a). TEA (0.5 ml) was added to a stirred ethanolic solution of methyl hydrazinecarbodithioate (10) (0.122 g, 1 mmol) and 2-oxo-N-phenylpropanehydrazonoyl chloride (5a) (0.196 g, 1 mmol). The reaction mixture was irradiated by an ultrasonic generator in a water bath at 40°C for 30 min. The solid precipitated after cooling and was filtered off, washed with water, dried, and finally recrystallized from DMF to give the corresponding product 11a, which was identical in all aspects (m.p., mixed m.p., and IR spectra) with those obtained from the one-pot synthesis of 3 + 10 + 5a.

Anticancer Activities

The cytotoxic evaluation of the synthesized compounds was carried out at the Regional Center for Mycology and Biotechnology at Al-Azhar University, Cairo, Egypt, according to the reported method (Gomha et al., 2015c; Gomha et al., 2015d). For more details, see the supporting information file.

Results and Discussion

In continuation of our previous work to synthesize bioactive heterocyclic compounds under mild conditions, herein we wish to report a mild and efficient procedure for the synthesis of some thiazolyl-coumarins via the one-pot, three-component reaction of 3-acetyl-6-methyl-2H-chromen-2-one (3) (prepared previously from the reaction of 1 with 2) (Scheme 1) (Toan et al., 2020), thiosemicarbazone (4), and the appropriate hydrazonoyl halides 5a–i [52] in dioxane under ultrasonic irradiation (USI) at 50°C for 20–60 min, in the presence of different basic catalysts such as TEA, chitosan, and chitosan-grafted poly(vinylpyridine) (Scheme 1). The development of all reactions was tracked by TLC. At the outset, the identification of the best basic catalyst was examined (Table 1).

SCHEME 1.

SCHEME 1

Open in a new tab

Synthesis of arylazothiazole derivatives 6a–i.

TABLE 1.

Comparison of synthesis of thiazolylcoumarines 6a–i under ultrasound irradiation using different basic catalysts on the time of reaction and the yield% of the products.

Compound no TEA Chitosan g-Chitosan a
Time (min) (%) Yield Time (min) (%) Yield Time (min) (%) Yield
6a 50 72 41 79 20 93
6b 50 74 43 83 23 89
6c 56 73 46 84 25 91
6d 53 72 43 84 28 94
6e 52 72 36 86 19 89
6f 60 72 38 83 25 88
6g 55 73 38 84 22 89
6h 50 72 37 84 26 90
6i 45 72 37 86 28 92
Open in a new tab
a

g-chitosan, chitosan-grafted poly(vinylpyridine); TEA, triethylamine.

As shown from Table 1, chitosan-grafted poly(vinylpyridine) was the best choice of a basic catalyst under USI. The reaction proceeds smoothly with an electron-rich as well as electron-deficient substituent on the aromatic benzene ring of hydrazonoyl halides 5. The structures of isolated products 6a–i were evidenced by spectral data together with elemental analyses. We have observed that under the same reaction conditions, the yields of the desired products 6a–i increase by changing TEA into chitosan. Moreover, using grafted chitosan as a basic catalyst has a significant increasing effect on the product yields. In addition, the heating under USI was more efficient than conventional heating, as it reduced the reaction time and increased the product yields in the case of compounds 6a–c as shown in Supplementary Table S1.

The elemental analyses and spectroscopic data of the obtained products 6a–i supported the assigned structures. The IR spectrum of 6a as a representative example exhibits two strong stretching frequencies in the regions of 3,427 and 1,724 cm−1, attributable to the NH and C═O groups, respectively. Its 1H-NMR spectrum displayed five singlet signals for the 3CH3, coumarin-H4, and NH protons at δ 2.13, 2.44, 2.67, 8.29, and 11.16 ppm, in addition to the characteristic multiplet signal for the eight aromatic protons. Moreover, its 13C-NMR showed three aliphatic signals for the three methyl groups at 11.3, 16.2, and 20.1 ppm; 15 aromatic signals at 115.6–151.4 ppm; and one carbonyl signal at 168.1 ppm. IR (KBr) spectra showed three bands at v 3,422, 1,671, and 1,653 cm−1 assignable to the NH and 2C═O groups. The mass spectrum is also an additional evidence for supporting the obtained structure, which gave a molecular ion at m/z 417.13 [M+] (Gomha et al., 2015b; Gomha et al., 2015c; Alshabanah et al., 2021; Gomha et al., 2021).

On the other hand, reaction of 2-(1-(6-methyl-2-oxo-2H-chromen-3-yl)ethylidene)hydrazine-1-carbothioamide (7) (prepared separately through condensation of 3-acetyl-6-methyl-2H-chromen-2-one (3) with thiosemicarbazide in ethanol containing drops of concentrated HCl) with 2-oxo-N-phenylpropanehydrazonoyl chloride (5a) (Shawali and Gomha, 2000) gave an identical product in IR, m.p., and mixed m.p. with 6a (Scheme 2). The overall yield for this 2-step reaction is 83%.

SCHEME 2.

SCHEME 2

Open in a new tab

Alternative synthesis of phenyazothiazole derivative 5a.

To achieve the best experimental conditions and the different factors (such as catalyst loading, temperature, solvent, and reaction time) on the reaction of 3 + 4 + 5a in the presence of a catalytic amount of chitosan-grafted poly(vinylpyridine) in one-pot synthesis under USI to get 6-methyl-3-(1-(2-(4-methyl-5-(phenyldiazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one (6a), the following was carried out.

In the first step, we examined the effect of the amount of catalyst for the synthesis of compound 6a (Table 2, entries 1–3). The best results were obtained using 10 mol% of catalyst (93%) (Table 2, entry 3). Using lower amounts of catalyst resulted in lower yields (Table 2).

TABLE 2.

Optimization of the reaction conditions (catalyst loading, solvent, reaction time, and temperature) for the synthesis of compound 6a.

Entry Catalyst (mol%) Solvent Time (min) Temperature (°C) Yield (%)
1 1 Dioxane 25 50 57
2 5 Dioxane 25 50 79
3 a 10 Dioxane 25 50 93
4 10 EtOH 25 50 90
5 10 DMSO 25 50 88
6 10 Dioxane 20 50 89
7 10 Dioxane 30 50 93
8 10 Dioxane 25 25 80
9 10 Dioxane 25 40 88
10 10 Dioxane 25 60 93
Open in a new tab
a

The best reaction condition for the synthesis of compound 6a.

In the next step, the efficiency of the different solvents was examined under USI (Table 2, entries 3–5). Screening of various solvents showed that the formation of product 6a proceeded in the highest yield with a higher reaction rate in dioxane (Table 2, entry 3).

Furthermore, the reaction time was examined under USI (Table 2, entries 3, 6, and 7). The best time for the formation of product 6a was 25 min (Table 2, entry 3).

In continuation, the effect of temperatures was also tested on the reaction, and the results are presented in Table 2 (entries 3, 8, 9, and 10). According to Table 2, increasing the reaction temperature from 25°C to 40°C–60°C under USI increases the yields of products from 80% to 88%–93%, respectively. Finally, 50°C was selected as the optimum temperature (Table 2, entry 3).

As shown in Table 2, we observed that the optimum reaction conditions for the formation of product 6a are as follows: reaction of 3 + 4 + 5a in dioxane under USI in the presence of 10 mol% of chitosan-grafted poly(vinylpyridine) at 50°C for 25 min.

Thus, irradiation of 3 + 4 + 5b–i under the optimum conditions led to the formation of 6-methyl-3-(1-(2-(4-substituted-5-(aryldiazenyl)thiazol-2-yl)hydrazono)ethyl)-2H-chromen-2-one derivatives 6b–i (Scheme 1).

Our research has now been expanded to include the synthesis of new 1,3,4-thiadiazole derivatives in an attempt to functionalize the target 3-thiadiazolyl coumarins 11a–f. Thus, treatment of compound 3, methyl hydrazinecarbodithioate (10), and various derivatives of hydrazonoyl halides 5a–f in EtOH under USI at 25°C for 10–30 min in the presence of TEA or the chitosan or chitosan-grafted poly(vinylpyridine) as a basic catalyst afforded the respective 1,3,4-thiadiazoles 11a–f as depicted in Scheme 3.

SCHEME 3.

SCHEME 3

Open in a new tab

Synthesis of thiadiazole derivatives 11a–f.

Table 3 shows the yield % of the isolated products 11a–f, the g-chitosan as a basic catalyst prevailed over chitosan and TEA under sonication technique.

TABLE 3.

Comparison of synthesis of thiadiazolylcoumarines 11a–f under USI using different basic catalysts on the time of reaction and the yield% of the products.

Compound no. TEA Chitosan g-Chitosan
Time (min) (%) Yield Time (min) (%) Yield Time (min) (%) Yield
11a 50 72 41 79 20 91
11b 50 74 43 83 23 89
11c 56 73 46 84 25 94
11d 53 72 43 84 28 88
11e 52 72 36 86 19 90
11f 60 72 38 83 25 89
Open in a new tab

Note. USI, ultrasonic irradiation; TEA, trimethylamine; g-chitosan, chitosan-grafted poly(vinylpyridine).

The structures of products 11a–f were elucidated based on spectral and analytical data as illustrated in the Methods and Methodology. For example, the IR spectra of the isolated products 11 revealed the existence of the characteristic bands for the two C═O groups at the normal wave numbers. The 1H-NMR spectra of compound 11a showed the expected signals at δ: 2.37, 2.44, 2.57 (3s, 3CH3), 8.56 (s, coumarin-H4) in addition to one multiplet signal at δ 7.21–7.44 ppm due to eight aromatic protons. 13C-NMR (DMSO-d 6) for compound 11a showed the characteristic signals for 3CH3 and the two C═O groups at δ 14.7, 20.1, 29.9, 168.5, and 195.0 ppm, in addition to the expected aromatic carbons. The mass spectra of products 11a–f revealed a molecular ion peak for each one, which is consistent with the respective molecular weight.

Alternatively, compound 11a was synthesized from a reaction of 2-oxo-N-phenylpropanehydrazonoyl chloride (5a) in EtOH containing a catalytic amount of g-chitosan under USI with carbothioamide 12 (prepared separately through condensation of compound 3 with methyl hydrazinecarbodithioate (10) in 2-propanol). The obtained product was found to be identical to 11a in all regards (m.p., TLC, and IR spectrum), which provides additional evidence to all 11a–f structures. The overall yield for this 2-step process was 78%.

Also, one-pot synthesis of 3 + 10 + 5a under USI in the presence of a catalytic amount of chitosan-grafted poly(vinylpyridine) was examined at different temperatures, solvents, and reaction times. This reaction led to the formation of 1,3,4-thiadiazole 11a.

In the first step, we examined the effect of different solvents under USI (Table 4, entries 1–3). Screening of various solvents showed that the formation of product 11a proceeded in the highest yield with a higher reaction rate in ethanol (Table 4, entry 1).

TABLE 4.

Optimization of the reaction conditions (solvent, reaction time, and temperature) for the synthesis of compound 11a.

Entry Catalyst (mol%) Solvent Time (min) Temperature (°C) Yield (%)
1 a 10 EtOH 15 25 91
2 10 Dioxane 15 25 81
3 10 DMSO 15 25 83
4 10 EtOH 10 25 86
5 10 EtOH 20 25 91
6 10 EtOH 15 50 91
Open in a new tab
a

The best reaction condition for the synthesis of compound 11a.

We also examined the reaction time under USI (Table 4, entries 1, 4, and 5). The best time for the formation of product 11a is 15 min (Table 4, entry 1).

Finally, we also tested the reaction temperatures, and the results are presented in Table 4 (entries 1 and 6). According to Table 4, increasing the reaction temperature from 25°C to 50°C did not affect the yield of the product. Finally, 25°C was selected as the optimum temperature (Table 4, entry 1).

As shown in Table 4, we can observe that the optimum reaction conditions for the formation of product 11a are as follows: reaction of 3 + 10 + 5a in ethanol under USI in the presence of 0.1 g of chitosan-grafted poly(vinylpyridine) at 25°C for 15 min.

Thus, irradiation of 3 + 10 + 5b–i under the optimum conditions led to formation of the respective 1,3,4-thiadiazole derivatives 11b–i (Scheme 3).

Generally, the formation of products 6a–i and 11a–f with the application of the USI/catalytic system in a three-component one-pot reaction gave high reaction yield in short reaction duration, and the achieved results showed the tremendous synergistic effect between g-chitosan and USI.

Antitumor Activity

The cytotoxic activity of the newly prepared compounds was determined against liver carcinoma cell line (HEPG2-1) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Doxorubicin was used as a reference drug. Data generated were used to plot a dose–response curve of which the concentration (µM) of the test compounds required to kill 50% of the cell population (IC50) was determined. The cytotoxic activity was expressed as the mean IC50 of three independent experiments (Table 5 and Figure 3). The results revealed that the descending order of activity of the tested compounds was as follows: 6d > 6b > 11e > 11d > 6c > 11c > 6a > 6f > 11b > 6e > 11a > 6i > 11f > 6h > 6g.

TABLE 5.

Cytotoxic activities of tested compounds against HEPG2-1.

Compd No R Ar IC50 (µM)
Doxorubicin − − 0.31 ± 0.48
6a Me C6H5 4.71 ± 0.72
6b Me 4-MeC6H4 0.43 ± 0.66
6c Me 3-MeC6H4 2.62 ± 0.75
6d Me 4-MeOC6H4 0.29 ± 0.45
6e Me 4-ClC6H4 5.79 ± 0.81
6f Me 4-BrC6H4 5.03 ± 0.56
6g Me 4-NO2C6H4 21.82 ± 0.79
6h Me 2,4-Cl2C6H3 19.20 ± 0.91
6i 2-Thienyl C6H5 11.37 ± 0.49
11a Me C6H5 7.06 ± 0.77
11b Me 4-MeC6H4 5.28 ± 0.73
11c OEt C6H5 3.27 ± 0.48
11d OEt 4-MeC6H4 1.73 ± 0.61
11e NHC6H5 C6H5 0.49 ± 0.38
11f 2-Thienyl C6H5 14.23 ± 0.59
Open in a new tab

FIGURE 3.

FIGURE 3

Open in a new tab

Cytotoxic activities of tested compounds against HEPG2-1.

Structure–Activity Relationship

The activities of the synthesized compounds depend on the structural skeleton and electronic environment of the molecules.

Based on our limited study, the 1,3-thiazole derivatives have an in vitro inhibitory activity greater than that of the 1,3,4-thiadiazole derivatives: (6a > 11a, 6b > 11b and 6i > 11f).

For the 1,3-thiazole ring 6a–i

The in vitro inhibitory activity of 4-methyl-thiazole derivative 6a was greater than that of 4-(2-thienyl)-thiazole derivative 6i.

The introduction of an electron-donating group (methyl or methoxy groups) enhanced the antitumor activity. In contrast, the introduction of the electron-withdrawing group (chlorine or bromine or nitro group) at C4 of the phenyl group at position 4 in the 1,3-thiazole ring decreased the activity: (6d, 6b > 6f, 6e, 6g).

The in vitro inhibitory activity of the 4-tolyl-thiazole derivative 6b was greater than that of 3-tolyl-thiazole derivative 6c.

The in vitro inhibitory activity of the 4-chlorophenyl-thiazole derivative 6e was greater than that of 2,4-dichlorophenyl-thiazole derivative 6h.

For 1,3,4-thiadiazoles 11a–f

The in vitro inhibitory activity of 5-substituted thiadiazoles was in the order of CONHPh > COOEt > CH3CO > 2-thienyl: (11e > 11c > 11a > 11f).

The in vitro inhibitory activity of 4-methyl-thiadiazole derivative 11a was greater than that of 4-(2-thienyl)-thiadiazole derivative 11f.

Generally, on fixing the substituents at position 5, the electron-donating group (methyl) at C4 of the phenyl ring enhances the antitumor activity, while the electron-withdrawing group (chlorine) decreases the activity: (11b > 11a and 11d > 11c).

Conclusion

A new, efficient, and regioselective method for the preparation of novel 3-azolyl-coumarins by reaction of 3-acetyl-6-methyl-2H-chromen-2-one, thiosemicarbazide, or methyl hydrazinecarbodithioate and the appropriate hydrazonoyl halides under ultrasound irradiation at ambient temperature in a short time and high yields was developed and discussed. The assigned structure for all the newly synthesized compounds was elucidated by elemental and spectral analysis data. Moreover, the new compounds were tested in vitro against the HEPG2-1 cell line using the MTT viability assay. Compounds 6b, 6d, and 11e have promising activities (IC50 value of 0.43 ± 0.66, 0.29 ± 0.45, and 0.49 ± 0.38 µM, respectively), compared with doxorubicin standard drug (IC50 value of 0.31 ± 0.48 µM).

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Author Contributions

Formal analysis: SG, HA, and LA-A. Funding acquisition: LA-A and LA. Methodology: SG and HA. Project administration: SG and LA. Resources: SG and HA. Writing—original draft: SG, LA, and HA. Writing—review and editing: HA and SG. All the authors approved the final version.

Funding

This research project was funded by the Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the Program of Research Project Funding after Publication, grant No (PRFA-P-42-7).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fchem.2021.762248/full#supplementary-material

Click here for additional data file. (363.3KB, PDF)

Abbreviations

DMF, dimethylformamide; DMSO-d 6, deuterated dimethylsulfoxide; EtOH, ethanol; g-chitosan, chitosan-grafted poly(vinylpyridine); HEPG2-1, liver carcinoma cell line; MCR, multicomponent reactions; MTT, mean transit time (brain tissue blood flow); TEA, triethylamine; TLC, thin-layer chromatography; USI, ultrasonic irradiation.

References

  1. Abbas I. M., Gomha S. M., Elneairy M. A. A., Elaasser M. M., Mabrouk B. K. H. (2015). Antimicrobial and Anticancer Evaluation of a Novel Synthetic Tetracyclic System Obtained by Dimroth Rearrangement. J. Serb. Chem. Soc. 80, 1251–1264. 10.2298/JSC141222022G [DOI] [Google Scholar]
  2. Alshabanah L. A., Gomha S. M., Al-Mutabagani L. A., Abolibda T. Z., El-Ghany N. A. A., El-Enany W. A. M. A., et al. (2021). Cross-Linked Chitosan/Multi-Walled Carbon Nanotubes Composite as Ecofriendly Biocatalyst for Synthesis of Some Novel Benzil Bis-Thiazoles. Polymers 13, 1728. 10.3390/polym13111728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bachman M., Mann S. E., Sheppard T. D. (2012). Rapid Synthesis of Highly Functionalised α-amino Amides and Medium Ring Lactones Using Multicomponent Reactions of Amino Alcohols and Isocyanides. Org. Biomol. Chem. 10, 162–170. 10.1039/c1ob06534c [DOI] [PubMed] [Google Scholar]
  4. Bhattarai N., Kumbhar A. A., Pokharel Y. R., Yadav P. N. (2021). Anticancer Potential of Coumarin and its Derivatives. Mrmc 21, 2996–3029. 10.2174/1389557521666210405160323 [DOI] [PubMed] [Google Scholar]
  5. Bhole R. P., Bhusari K. P. (2010). Synthesis and Antitumor Activity of (4-Hydroxyphenyl)[5-Substituted Alkyl/aryl)-2-Thioxo-1,3,4-Thiadiazol-3-Yl]methanone and [(3,4-Disubstituted)-1,3-Thiazol-2ylidene]-4-Hydroxybenzohydrazide. Med. Chem. Res. 20, 695–704. 10.1007/s00044-010-9371-9 [DOI] [Google Scholar]
  6. Cravotto G., Cintas P. (2006). Power Ultrasound in Organic Synthesis: Moving Cavitational Chemistry from Academia to Innovative and Large-Scale Applications. Chem. Soc. Rev. 35, 180–196. 10.1039/b503848k [DOI] [PubMed] [Google Scholar]
  7. Cravotto G., Fokin V. V., Garella D., Binello A., Boffa L., Barge A. (2010). Ultrasound-Promoted Copper-Catalyzed Azide−Alkyne Cycloaddition. J. Comb. Chem. 12, 13–15. 10.1021/cc900150d [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dawood K. M., Gomha S. M. (2015). Synthesis and Anti-cancer Activity of 1,3,4-Thiadiazole and 1,3-Thiazole Derivatives Having 1,3,4-Oxadiazole Moiety. J. Heterocyclic Chem. 52, 1400–1405. 10.1002/jhet.2250 [DOI] [Google Scholar]
  9. Ekowati H., Astuti I., Mustofa M. (2010). Anticancer Activity of Calanone on Hela Cell Line. Indo. J. Chem. 10, 240–244. 10.22146/ijc.21467 [DOI] [Google Scholar]
  10. Emami S., Dadashpour S. (2015). Current Developments of Coumarin-Based Anti-cancer Agents in Medicinal Chemistry. Eur. J. Med. Chem. 102, 611–630. 10.1016/j.ejmech.2015.08.033 [DOI] [PubMed] [Google Scholar]
  11. Fu C.-C., Hung T.-C., Su C.-H., Suryani D., Wu W.-T., Dai W.-C., et al. (2011). Immobilization of Calcium Oxide onto Chitosan Beads as a Heterogeneous Catalyst for Biodiesel Production. Polym. Int. 60, 957–962. 10.1002/pi.3031 [DOI] [Google Scholar]
  12. Geisler J., Sasano H., Chen S., Purohit A. (2011). Steroid Sulfatase Inhibitors: Promising New Tools for Breast Cancer Therapy? Steroid Biochem. Mol. Biol. 125, 39–45. 10.1016/j.jsbmb.2011.02.002 [DOI] [PubMed] [Google Scholar]
  13. Gomes J. P. M., Cardoso C. R. P., Varanda E. A., Molina J.-M., Fernandez M. F., Olea N., et al. (2011). Antitumoral, Mutagenic and (Anti)estrogenic Activities of Tingenone and Pristimerin. Rev. Bras. Farmacogn. 21, 963–971. 10.1590/s0102-695x2011005000153 [DOI] [Google Scholar]
  14. Gomha S., Kheder N., Abdelhamid A., Mabkhot Y. (2016). One Pot Single Step Synthesis and Biological Evaluation of Some Novel Bis(1,3,4-Thiadiazole) Derivatives as Potential Cytotoxic Agents. Molecules 21, 1532. 10.3390/molecules21111532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gomha S. M., Abdel-Aziz H. M. (2015). Synthesis and Antitumor Activity of 1,3,4-Thiadiazole Derivatives Bearing Coumarine Ring. Heterocycles 91, 583–592. 10.3987/com-14-13146 [DOI] [Google Scholar]
  16. Gomha S. M., Abdelaziz M. R., Abdel-aziz H. M., Hassan S. A. (2017). Green Synthesis and Molecular Docking of Thiazolyl-Thiazole Derivatives as Potential Cytotoxic Agents. Mrmc 17, 805–815. 10.2174/1389557516666161223154539 [DOI] [PubMed] [Google Scholar]
  17. Gomha S. M., Abdelhady H. A., Hassain D. Z., Abdelmonsef A. H., El-Naggar M., Elaasser M. M., et al. (2021). Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study. Dddt Vol. 15, 659–677. 10.2147/dddt.s291579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gomha S. M., Abdelrazek F. M., Abdelrahman A. H., Metz P., Mohsen A., Sayed M. A. (2017). A Facile Synthesis and Drug Design of Some New Heterocyclic Compounds Incorporating Pyridine Moiety and Their Antimicrobial Evaluation. Lett. Drug Des. Disc. 14, 752–762. 10.2174/1570180814666161128120240 [DOI] [Google Scholar]
  19. Gomha S. M., Badrey M. G., Edrees M. M. (2016). Heterocyclisation of 2,5-Diacetyl-3,4-Disubstituted-Thieno[2,3-b]Thiophene Bis-Thiosemicarbazones Leading to Bis-Thiazoles and Bis-1,3,4-Thiadiazoles as Anti-breast Cancer Agents. J. Chem. Res. 40, 120–125. 10.3184/174751916x14537182696214 [DOI] [Google Scholar]
  20. Gomha S. M., Riyadh S. M., Mahmmoud E. A., Elaasser M. M. (2015). Synthesis and Anticancer Activities of Thiazoles, 1,3-Thiazines, and Thiazolidine Using Chitosan-Grafted-Poly(vinylpyridine) as Basic Catalyst. Heterocycles 91, 1227. 10.3987/COM-15-13210 [DOI] [Google Scholar]
  21. Gomha S. M., Riyadh S. M., Mahmmoud E. A., Elaasser M. M. (2015). Synthesis and Anticancer Activity of Arylazothiazoles and 1,3,4-thiadiazoles Using Chitosan-Grafted-Poly(4-Vinylpyridine) as a Novel Copolymer Basic Catalyst. Chem. Heterocycl. Comp. 51, 1030–1038. 10.1007/s10593-016-1815-9 [DOI] [Google Scholar]
  22. Gomha S. M., Riyadh S. M. (2014). Multicomponent Synthesis of Novel Penta-Heterocyclic Ring Systems Incorporating a Benzopyranopyridine Scaffold. Synthsis 46, 258–262. 10.1055/s-0033-1340085 [DOI] [Google Scholar]
  23. Gomha S. M., Salah T. A., Abdelhamid A. O. (2015). Synthesis, Characterization, and Pharmacological Evaluation of Some Novel Thiadiazoles and Thiazoles Incorporating Pyrazole Moiety as Anticancer Agents. Monatsh. Chem. 146, 149–158. 10.1007/s00706-014-1303-9 [DOI] [Google Scholar]
  24. Gomha S., Zaki Y., Abdelhamid A. (2015). Utility of 3-Acetyl-6-Bromo-2h-Chromen-2-One for the Synthesis of New Heterocycles as Potential Antiproliferative Agents. Molecules 20, 21826–21839. 10.3390/molecules201219803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Guibal E. (2005). Heterogeneous Catalysis on Chitosan-Based Materials: a Review. Prog. Polym. Sci. 30, 71–109. 10.1016/j.progpolymsci.2004.12.001 [DOI] [Google Scholar]
  26. Gupta K. C., Ravi Kumar M. N. V. (2000). Preparation, Characterization and Release Profiles of pH-Sensitive Chitosan Beads. Polym. Int. 49, 141–146. [DOI] [Google Scholar]
  27. Jarag K. J., Pinjari D. V., Pandit A. B., Shankarling G. S. (2011). Synthesis of Chalcone (3-(4-Fluorophenyl)-1-(4-Methoxyphenyl)prop-2-En-1-One): Advantage of Sonochemical Method over Conventional Method. Ultrason. Sonochem. 18, 617–623. 10.1016/j.ultsonch.2010.09.010 [DOI] [PubMed] [Google Scholar]
  28. Kashyap A., Adhikari N., Das A., Shakya A., Ghosh S. K., Singh U. P., et al. (2018). Review on Synthetic Chemistry and Antibacterial Importance of Thiazole Derivatives. Curr. Drug Discov. Technol. 15, 214–228. 10.2174/1570163814666170911144036 [DOI] [PubMed] [Google Scholar]
  29. Kumar D., Kumar N. M., Chang K.-H., Shah K. (2010). Synthesis and Anticancer Activity of 5-(3-Indolyl)-1,3,4-Thiadiazoles. Eur. J. Med. Chem. 45, 4664–4668. 10.1016/j.ejmech.2010.07.023 [DOI] [PubMed] [Google Scholar]
  30. Li J., Wang X.-L., Fang Y.-C., Wang C.-Y. (2010). Tephrosin-induced Autophagic Cell Death in A549 Non-small Cell Lung Cancer Cells. J. Asian Nat. Prod. Res. 12, 992–1000. 10.1080/10286020.2010.513034 [DOI] [PubMed] [Google Scholar]
  31. Liaras K., Fesatidou M., Geronikaki A. (2018). Thiazoles and Thiazolidinones as COX/LOX Inhibitors. Molecules 685, 23. 10.3390/molecules23030685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lin M.-H., Cheng C.-H., Chen K.-C., Lee W.-T., Wang Y.-F., Xiao C.-Q., et al. (2014). Induction of ROS-independent JNK-Activation-Mediated Apoptosis by a Novel Coumarin-Derivative, DMAC, in Human colon Cancer Cells. Chem. Bio. Int. 218, 42–49. 10.1016/j.cbi.2014.04.015 [DOI] [PubMed] [Google Scholar]
  33. Luzina E. L., Popov A. V. (2009). Synthesis and Anticancer Activity of N-Bis(trifluoromethyl)alkyl-N′-Thiazolyl and N-Bis(trifluoromethyl)alkyl-N′-Benzothiazolyl Ureas. Eur. J. Med. Chem. 44, 4944–4953. 10.1016/j.ejmech.2009.08.007 [DOI] [PubMed] [Google Scholar]
  34. Mamaghani M., Hossein Nia R. (2021). A Review on the Recent Multicomponent Synthesis of Pyranopyrazoles. Polycyclic Aromatic Compd. 41, 223–291. 10.1080/10406638.2019.1584576 [DOI] [Google Scholar]
  35. Marcaccini S., Miguel D., Torroba T., García-Valverde M. (2003). 1,4-Thiazepines, 1,4-Benzothiazepin-5-Ones, and 1,4-Benzothioxepin Orthoamides via Multicomponent Reactions of Isocyanides. J. Org. Chem. 68, 3315–3318. 10.1021/jo026614z [DOI] [PubMed] [Google Scholar]
  36. Matysiak J., Opolski A. (2006). Synthesis and Antiproliferative Activity of N-Substituted 2-Amino-5-(2,4-Dihydroxyphenyl)-1,3,4-Thiadiazoles. Bioorg. Med. Chem. 14, 4483–4489. 10.1016/j.bmc.2006.02.027 [DOI] [PubMed] [Google Scholar]
  37. Mavrova A. T., Wesselinova D., Tsenov Y. A., Denkova P. (2009). Synthesis, Cytotoxicity and Effects of Some 1,2,4-triazole and 1,3,4-thiadiazole Derivatives on Immunocompetent Cells. Eur. J. Med. Chem. 44, 63–69. 10.1016/j.ejmech.2008.03.006 [DOI] [PubMed] [Google Scholar]
  38. Nishino H., Okuyama T., Takata M., Shibata S., Tokuda H., Takayasu J., et al. (1990). Studies on the Anti-tumor-promoting Activity of Naturally Occurring Substances. IV. Pd-II [(+)anomalin, (+)praeruptorin B], a Seselin-type Coumarin, Inhibits the Promotion of Skin Tumor Formation by 12-O-Tetradecanoylphorbol-13-Acetate in 7,12-Dimethylbenz[a]anthracene-Initiated Mice. Carcinogenesis 11, 1557–1561. 10.1093/carcin/11.9.1557 [DOI] [PubMed] [Google Scholar]
  39. Pizzuti L., Martins P. L. G., Ribeiro B. A., Quina F. H., Pinto E., Flores A. F. C., et al. (2010). Efficient Sonochemical Synthesis of Novel 3,5-Diaryl-4,5-Dihydro-1h-Pyrazole-1-Carboximidamides. Ultrason. Sonochem. 17, 34–37. 10.1016/j.ultsonch.2009.06.013 [DOI] [PubMed] [Google Scholar]
  40. Popsavin M., Spaić S., Svirčeva M., Kojić V., Bogdanović G., Popsavin V. (2007). Synthesis and Antitumour Activity of New Tiazofurin Analogues Bearing a 2,3-anhydro Functionality in the Furanose Ring. Bioorg. Med. Chem. Lett. 17, 4123–4127. 10.1016/j.bmcl.2007.05.050 [DOI] [PubMed] [Google Scholar]
  41. Qin Y., Zhao W., Yang L., Zhang X., Cui Y. (2012). Chitosan-Based Heterogeneous Catalysts for Enantioselective Michael Reaction. Chirality 24, 640–645. 10.1002/chir.22058 [DOI] [PubMed] [Google Scholar]
  42. Saidu N. E. B., Valente S., Bana E., Kirsch G., Bagrel D., Montenarh M. (2012). Coumarin Polysulfides Inhibit Cell Growth and Induce Apoptosis in HCT116 colon Cancer Cells. Bioorg. Med. Chem. 20, 1584–1593. 10.1016/j.bmc.2011.12.032 [DOI] [PubMed] [Google Scholar]
  43. Shaabani A., Soleimani E., Khavasi H. R. (2008). Synthesis of 1-Aminoimidazo[5,1-A]isoquinolinium Salts Based on Multicomponent Reactions of Isocyanides. J. Comb. Chem. 10, 442–446. 10.1021/cc700196h [DOI] [PubMed] [Google Scholar]
  44. Shawali A. S., Gomha S. M. (2000). A New Entry for Short and Regioselective Synthesis of [1,2,4]Triazolo[4,3-B][1,2,4]-Triazin-7(1h)-Ones. J. Prakt. Chem. 342, 599–604. [DOI] [Google Scholar]
  45. Singh B. S., Lobo H. R., Pinjari D. V., Jarag K. J., Pandit A. B., Shankarling G. S. (2013). Comparative Material Study and Synthesis of 4-(4-Nitrophenyl)oxazol-2-Amine via Sonochemical and thermal Method. Ultrason. Sonochem. 20, 633–639. 10.1016/j.ultsonch.2012.09.002 [DOI] [PubMed] [Google Scholar]
  46. Tao Z., Gomha S. M., Badrey M. G., El-Idreesy T. T., Eldebss T. M. A. (2018). Novel 4-Heteroaryl-Antipyrines: Synthesis, Molecular Docking, and Evaluation as Potential Anti-breast Cancer Agents. J. Heterocyclic Chem. 55, 2408–2416. 10.1002/jhet.3305 [DOI] [Google Scholar]
  47. Thakur A., Singla R., Jaitak V. (2015). Coumarins as Anticancer Agents: A Review on Synthetic Strategies, Mechanism of Action and SAR Studies. Eur. J. Med. Chem. 101, 476–495. 10.1016/j.ejmech.2015.07.010 [DOI] [PubMed] [Google Scholar]
  48. Toan V. N., Thanh N. D., Tri N. M., Huong N. T. T. (2020). Synthesis and Biological Screening of Thiosemicarbazones of Substituted 3-acetylcoumarins Having D-Glucose Moiety. Bioorg. Med. Chem. Lett. 30, 127664. 10.1016/j.bmcl.2020.127664 [DOI] [PubMed] [Google Scholar]
  49. Vosooghi M., Rajabalian S., Sorkhi M., Badinloo M., Nakhjiri M., Negahbani A. S., et al. (2010). Synthesis and Cytotoxic Activity of Some 2-Amino-4-Aryl-3-Cyano-7-(dimethylamino)-4h-Chromenes. Res. Pharm. Sci. 5, 9–14. [PMC free article] [PubMed] [Google Scholar]
  50. Wang S., Zhao Y., Zhang G., Lv Y., Zhang N., Gong P. (2011). Design, Synthesis and Biological Evaluation of Novel 4-thiazolidinones Containing Indolin-2-One Moiety as Potential Antitumor Agent. Eur. J. Med. Chem. 46, 3509–3518. 10.1016/j.ejmech.2011.05.017 [DOI] [PubMed] [Google Scholar]
  51. Watile R. A., Bhanage B. M. (2012). Chitosan Biohydrogel Beads: A Recyclable, Biodegradable, Heterogeneous Catalyst for the Regioselective Synthesis of 5-Aryl-2-Oxazolidinones from Carbon Dioxide and Aziridines at Mild Conditions. Ind. J. Chem. 51A, 1354–1360. [Google Scholar]
  52. Xu H., Liao W.-M., Li H.-F. (2007). A Mild and Efficient Ultrasound-Assisted Synthesis of Diaryl Ethers without Any Catalyst. Ultrason. Sonochem. 14, 779–782. 10.1016/j.ultsonch.2007.01.002 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (363.3KB, PDF)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES